Geron | GERN - Revenu Net

Prix De L'Action
1.60
Variation Quotidienne
-0.05 -3.03%
Mensuellement
-8.57%
Annuel
21.21%
Q2 Prévisions
1.55




Revenu Net Changement Date
Amgen USD 1.82B 486M 2026-03
Bio Techne USD 38.01M 176K 2025-12
Cassava Sciences USD -12.54M 1.73M 2025-12
Cytokinetics USD -206.03M 23M 2026-03
Esperion Therapeutics USD 61.83M 93.16M 2025-12
Exelixis USD 244.53M 50.95M 2025-12
Genmab DKK 31M 370M 2025-12
Geron USD -31.14M 12.72M 2025-12
Gilead Sciences USD 2.18B 869M 2025-12
Incyte USD 303.33M 4.05M 2026-03
MacroGenics USD -14.16M 30.98M 2025-12
Novartis USD 3.16B 747M 2026-03
Novavax USD 17.53M 219.91M 2025-12